CIP
Champlain Investment Partners Portfolio holdings
AUM
$14.3B
This Quarter Return
+9.06%
1 Year Return
+15.77%
3 Year Return
+62.69%
5 Year Return
+103.93%
10 Year Return
+328.08%
AUM
$6.59B
AUM Growth
+$786M
(+14%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
22.93%
Holding
154
New
14
Increased
61
Reduced
57
Closed
13
Top Buys
| 1 |
Treehouse Foods
THS
|
$45.2M |
| 2 |
WBT
Welbilt, Inc.
WBT
|
$41.9M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$40.9M |
| 4 |
DATA
Tableau Software, Inc.
DATA
|
$34.1M |
| 5 |
Akamai
AKAM
|
$32.4M |
Top Sells
| 1 |
CST
CST Brands, Inc.
CST
|
$31.5M |
| 2 |
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
|
$27.9M |
| 3 |
PROS Holdings
PRO
|
$23.4M |
| 4 |
STJ
St Jude Medical
STJ
|
$23.2M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
$20M |
Sector Composition
| 1 | Healthcare | 20.14% |
| 2 | Financials | 18.26% |
| 3 | Technology | 16.8% |
| 4 | Industrials | 16.64% |
| 5 | Consumer Staples | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
126
DELISTED
Express Scripts Holding Company
ESRX
| $381K | 0.01% |
5,400
+600
| +13% | +$42.3K |
|
|
ABCO
127
DELISTED
Advisory Board Co/The
ABCO
| $348K | 0.01% |
7,775
+825
| +12% | +$36.9K |
|
128
Gilead Sciences
GILD
$140B
| $316K | ﹤0.01% |
+4,000
| New | +$316K |
|
129
Wells Fargo
WFC
$258B
| $310K | ﹤0.01% |
+7,000
| New | +$310K |
|
130
Teva Pharmaceuticals
TEVA
$21.5B
| $299K | ﹤0.01% |
+6,500
| New | +$299K |
|
131
PayPal
PYPL
$66.5B
| $274K | ﹤0.01% |
+6,700
| New | +$274K |
|
132
Amgen
AMGN
$153B
| $267K | ﹤0.01% |
1,600
| – | – |
|
133
Phillips 66
PSX
$52.8B
| $266K | ﹤0.01% |
+3,300
| New | +$266K |
|
134
Suncor Energy
SU
$49.3B
| $264K | ﹤0.01% |
9,500
| – | – |
|
|
POT
135
DELISTED
Potash Corp Of Saskatchewan
POT
| $258K | ﹤0.01% |
15,800
+800
| +5% | +$13.1K |
|
136
Unilever
UL
$158B
| $256K | ﹤0.01% |
5,400
+900
| +20% | +$42.7K |
|
137
American Express
AXP
$225B
| $224K | ﹤0.01% |
3,500
| – | – |
|
138
Cognizant
CTSH
$35.1B
| $224K | ﹤0.01% |
+4,700
| New | +$224K |
|
139
Chubb
CB
$111B
| $214K | ﹤0.01% |
1,700
-300
| -15% | -$37.8K |
|
|
MON
140
DELISTED
Monsanto Co
MON
| $204K | ﹤0.01% |
2,000
| – | – |
|
141
Cameco
CCJ
$33.6B
| $160K | ﹤0.01% |
18,700
+5,700
| +44% | +$48.8K |
|
142
Avanos Medical
AVNS
$573M
| – | – |
-92,685
| Closed | -$3.01M |
|
143
BP
BP
$88.8B
| – | – |
-7,131
| Closed | -$213K |
|
|
BZUN
144
Baozun
BZUN
$233M
| – | – |
-70,000
| Closed | -$454K |
|
145
Edwards Lifesciences
EW
$47.7B
| – | – |
-478,170
| Closed | -$15.9M |
|
146
Johnson & Johnson
JNJ
$429B
| – | – |
-1,800
| Closed | -$218K |
|
147
James River Group
JRVR
$256M
| – | – |
-86,890
| Closed | -$2.95M |
|
148
Phibro Animal Health
PAHC
$1.55B
| – | – |
-190,760
| Closed | -$3.56M |
|
|
149
PROS Holdings
PRO
$734M
| – | – |
-1,343,340
| Closed | -$23.4M |
|
150
Qualcomm
QCOM
$170B
| – | – |
-5,500
| Closed | -$295K |
|